357 filings
Page 10 of 18
SUPPL
TRIL
Trillium Therapeutics Inc.
25 Feb 19
Supplemental materials (foreign)
5:03pm
6-K
TRIL
Trillium Therapeutics Inc.
22 Feb 19
Trillium Announces Pricing of US$15 Million Public Offering of Common Share Units and Series Ii Non-voting Convertible First Preferred Share Units
9:01am
SUPPL
TRIL
Trillium Therapeutics Inc.
21 Feb 19
Supplemental materials (foreign)
8:37pm
6-K
TRIL
Trillium Therapeutics Inc.
21 Feb 19
Trillium Announces Proposed Public Offering of Common Share Units and Series Ii Non-voting Convertible First Preferred Share Units
4:05pm
SC 13G/A
Cormorant Asset Management, LP
14 Feb 19
Trillium Therapeutics Inc.
4:03pm
SC 13G/A
Matrix Capital Management Company, LP
14 Feb 19
Trillium Therapeutics Inc.
2:39pm
SC 13G/A
TRIL
Trillium Therapeutics Inc.
12 Feb 19
Trillium Therapeutics Inc.
11:05am
SC 13G/A
TRIL
Trillium Therapeutics Inc.
10 Jan 19
Trillium Therapeutics Inc.
3:39pm
SC 13G
TRIL
Trillium Therapeutics Inc.
21 Dec 18
Trillium Therapeutics Inc.
4:03pm
6-K
TRIL
Trillium Therapeutics Inc.
3 Dec 18
Current report (foreign)
7:00am
6-K
TRIL
Trillium Therapeutics Inc.
14 Nov 18
Interim Condensed Consolidated Financial Statements
7:00am
6-K
TRIL
Trillium Therapeutics Inc.
28 Sep 18
Current report (foreign)
7:19am
6-K
TRIL
Trillium Therapeutics Inc.
27 Sep 18
Trillium Therapeutics to Present at Upcoming Investor Conferences
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
12 Sep 18
Updated safety and efficacy data from the TTI-621 intravenous trial at the 16thAnnual Discovery on Target Conference
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
30 Aug 18
TRILLIUM TO PRESENT AT THE 20th ANNUAL RODMAN & RENSHAW GLOBAL INVESTMENT CONFERENCE
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
8 Aug 18
Interim Condensed Consolidated Financial Statements
7:00am
6-K
TRIL
Trillium Therapeutics Inc.
25 Jun 18
Form 51-102F3 Material Change Report
10:34am
SUPPL
TRIL
Trillium Therapeutics Inc.
20 Jun 18
Supplemental materials (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
20 Jun 18
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
20 Jun 18
Current report (foreign)
12:00am